Patents Examined by Douglas F White
  • Patent number: 8735057
    Abstract: The invention herein disclosed provides for compositions, methods for synthesizing said compositions, and methods for using said compositions, wherein the compositions and methods may be used to bind to and/or deactivate a poison oak oil, such as urushiol. The compositions and methods can be used to treat and/or reduce an inflammatory reaction and/or hypersensitivity to natural compounds found in poison oak, poison ivy, poison sumac, mango, lac tree, and cashew nut.
    Type: Grant
    Filed: December 14, 2012
    Date of Patent: May 27, 2014
    Assignee: The Regents of the University of California
    Inventor: Rebecca Braslau
  • Patent number: 8735155
    Abstract: Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: May 27, 2014
    Assignee: CorMatrix Cardiovascular, Inc.
    Inventor: Robert G Matheny
  • Patent number: 8728782
    Abstract: Disclosed is a method of converting butyric acid contained in a fermentation broth into biofuel. This chemical conversion method includes separating biohydrogen from gases generated in the course of production of butyric acid through fermentation of carbohydrate, extracting butyric acid from the broth using an insoluble solvent, esterifying butyric acid thus producing butylbutyrate, and hydrogenolyzing all or part of butylbutyrate, thus obtaining butanol. Thereby, biobutanol can be efficiently and economically produced, and butylbutyrate, which has oxidation stability superior to that of conventional biodiesel (fatty acid methyl ester) and is thus regarded as novel biofuel, can be produced together.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: May 20, 2014
    Assignees: SK Innovation Co., Ltd., Korea Institute of Science and Technology
    Inventors: Sin Young Kang, Cher Hee Park, Young Seek Yoon, In Ho Cho, Hyung Woong Ahn, Sam Ryong Park, Jong Hee Song, Seong Ho Lee, Byoung In Sang, Young Woong Suh, Young Soon Um, Sun Mi Lee
  • Patent number: 8709399
    Abstract: The present invention relates to a new method for pest control and/or for preventing or treating pest infestation. Said method comprises the inoculation of plants, parts of plants or the surrounding of said plants with an effective amount of endophytic Beauveria bassiana strains. In a further aspect the present invention relates to the use of an isolated Beauveria bassiana strain having superior properties. Furthermore, biopesticides and compositions for pest control, in particular, for control of herbivorous insects and/or plant pathogens, are provided.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: April 29, 2014
    Assignee: Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts
    Inventors: Stefan Vidal, Tadele Tefera
  • Patent number: 8691276
    Abstract: Provided are methods for preparing gelled, solubilized extracellular matrix (ECM) compositions useful as cell growth scaffolds. Also provided are compositions prepared according to the methods as well as uses for the compositions. In one embodiment a device, such as a prosthesis, is provided which comprises an inorganic matrix into which the gelled, solubilized ECM is dispersed to facilitate in-growth of cells into the ECM and thus adaptation and/or attachment of the device to a patient.
    Type: Grant
    Filed: November 26, 2012
    Date of Patent: April 8, 2014
    Assignee: University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Stephen F. Badylak, Donald Freytes
  • Patent number: 8685388
    Abstract: The present invention relates to a method for the prevention, treatment and reduction of gastro-intestinal inflammation in a subject by administering a specific Bifidobacterium bacteria, in particular a fermented dairy product comprising said specific Bifidobacterium bacteria for the prevention, treatment and reduction of gastro-intestinal inflammation, in particular for the prevention and treatment of inflammatory bowel disease (IBD), ulcerative colitis (UC) and/or Crohn's Disease (CD) and for the prevention and treatment of Irritable Bowel Syndrome (IBS).
    Type: Grant
    Filed: November 2, 2009
    Date of Patent: April 1, 2014
    Assignees: Compagnie Gervais Danone, President and Fellows of Harvard College
    Inventors: Patrick Veiga, Isabelle Chambaud, Artem Khlebnikov, Laurie H. Glimcher, Wendy S. Garrett
  • Patent number: 8685707
    Abstract: The present disclosure describes use of filamentous algae to form insulating construction materials which provide thermal and noise insulation. Algae from the order Zygnematales, the Cladophorales, or the Ulotrichales can be dried and formed for use as insulating material. Algae mass can be combined into several layers, using a binder to attach the layers to each other. A composite material of algae mass and an additive can be used and form the body of insulation panels having honeycomb-shaped chambers, which are sealed by a foil that is laminated onto the body. Various plants for cultivating algae for use in construction material are disclosed. Plants utilizing gravity harvest comprise cultivation ponds located at a slope, wherein the ponds can be opened to allow algae and water to flow downhill through a collector grill. Plants utilizing net harvest, overflow harvest or rake harvest are described.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: April 1, 2014
    Inventor: Heinz Ploechinger
  • Patent number: 8673616
    Abstract: The present invention relates to a novel wild-type Lactococcus lactis subsp. cremoris bacteria strain with increased vitamin K2 production and mutants and variants thereof and methods for preparation of a fermented food or feed product enriched in vitamin K2 and a vitamin K enriched edible product for amelioration and/or prevention of vitamin K deficiency. The present invention also relates to the fermented food or feed product and the edible product obtainable by the methods herein and to the wild-type Lactococcus lactis subsp. cremoris bacteria strain for use in treatment and/or prevention of vitamin K deficiency in a mammal, such as a human.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: March 18, 2014
    Assignee: CHR. Hansen A/S
    Inventors: Christel Garrigues, Martin Bastian Pedersen
  • Patent number: 8673640
    Abstract: A porous scaffold having pores for seeding cells characterized in that, in the outer peripheral face of the porous main body having the pores for seeding cells, a porous membrane having pores smaller than the cells is located. Thus, it is possible to provide a porous scaffold whereby the cells can be seeded at a high efficiency while preventing cell leakage and, moreover, even cells having little adhesiveness can be adhered.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: March 18, 2014
    Assignee: National Institute for Materials Science
    Inventors: Guoping Chen, Tetsuya Tateishi, Junzo Tanaka
  • Patent number: 8673983
    Abstract: The present invention provides an enzymatic and a chemical synthesis of melanins and novel melanins.
    Type: Grant
    Filed: December 22, 2008
    Date of Patent: March 18, 2014
    Assignee: Loyola University Chicago
    Inventors: Earle W. Holmes, Kenneth D. Thompson
  • Patent number: 8663949
    Abstract: This invention relates to the integration of an ammonia production process with a fermentation process to produce products such as alcohols and/or acids in addition to ammonia. In a specific embodiment, a natural gas stream comprising methane is passed to a reforming zone to produce a substrate comprising CO and H2. The substrate is next passed to a bioreactor containing a culture of one or more microorganisms and fermenting the culture to produce one or more fermentation products comprising alcohols and/or acids and an exhaust stream comprising CO2, and H2. The exhaust stream can then be passed to a separation zone to remove at least a portion of the CO2 and produce a purified exhaust stream comprising H2 which is then passed to an ammonia production zone and is used to produce ammonia.
    Type: Grant
    Filed: December 19, 2011
    Date of Patent: March 4, 2014
    Assignee: LanzaTech New Zealand Limited
    Inventor: Michael Anthony Schultz
  • Patent number: 8658196
    Abstract: Described, in certain aspects of the invention, are multilaminate medical graft products, as well as methods for preparing and using the same. An illustrative multilaminate medical graft product of the invention comprises a first layer of remodelable extracellular matrix (ECM) material bonded to a second layer of remodelable ECM material, wherein the first material layer is enriched with a growth factor relative to the second material layer. Such a remodelable ECM material may be comprised of submucosa from a warm-blooded vertebrate, for example, porcine small intestinal submucosa (SIS).
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: February 25, 2014
    Assignee: Cook Biotech Incorporated
    Inventor: Abram D. Janis
  • Patent number: 8617871
    Abstract: The present invention relates to an improved culture medium and method for the enhanced growth and detection of Mycobacterium growth. The invention further relates to an improved mycobacterial reagent system or kit that can be used for the enhanced growth and detection of Mycobacterium.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: December 31, 2013
    Assignee: bioMerieux, Inc.
    Inventors: Parampal Deol, Leticia Barton, Yoany Portilla, Douglas Lovern
  • Patent number: 8597934
    Abstract: Ethanol and other liquid products are produced from biomass using gasification of the biomass to produce a syngas containing CO2, CO, H2 and sulfur or sulfur compounds that passes the syngas to a fermentation step for the conversion of the CO and CO2 and H2 to ethanol. Sulfur and sulfur compounds in the syngas are used to satisfy sulfur demanded by bacteria in the fermentation step. A sulfur control additive is added to the gasification to control syngas sulfur and sulfur compounds at a desired concentration to meet bacteria sulfur demand.
    Type: Grant
    Filed: October 28, 2010
    Date of Patent: December 3, 2013
    Assignee: Coskata, Inc.
    Inventor: Richard E. Tobey
  • Patent number: 8591882
    Abstract: An object of the present invention is to find a novel and useful component in a culture supernatant of a lactic acid bacterium and to provide an effective utilization method of the component. The utilization method is a cytoprotective agent containing, as an active ingredient, a low-molecular-weight fraction in a culture supernatant of a lactic acid bacterium belonging to Streptococcus thermophilus.
    Type: Grant
    Filed: August 12, 2011
    Date of Patent: November 26, 2013
    Assignee: Kabushiki Kaisha Yakult Honsha
    Inventors: Naoki Izawa, Tomoko Kurasawa, Toshiro Sone, Katsuyoshi Chiba
  • Patent number: 8591880
    Abstract: The present invention relates to supporting weight management, weight loss and/or to the prevention and/or treatment of metabolic disorders. In particular the present invention relates to preventing and/or treating metabolic disorders by modulating, in particular reducing the amount of proteobacteria and/or deferribacteres in the gut. One embodiment of the present invention relates to the use of a primary composition comprising an agent that reduces the amount of proteobacteria, preferably gamma-proteobacteria, even more preferred enterobacteria; and/or deferribacteres in the gut for the preparation of a composition to treat or prevent metabolic disorders, to support weight loss and/or to support weight management.
    Type: Grant
    Filed: July 25, 2008
    Date of Patent: November 26, 2013
    Assignee: Nestec S.A.
    Inventors: Chieh Jason Chou, David Philippe, Christian Darlmont, Fabrizio Arigoni, Catherine Mace
  • Patent number: 8591911
    Abstract: A novel ascomycetous Xylogone ganodermophthora strain has antifungal activity. A composition includes the strain as an active ingredient for preventing plant diseases. A method for producing the composition includes culturing the strain, and a method for preventing plant diseases includes using the strain. The strain suppresses the growth of pathogenic fungi, including Phytophthora capsici, in plants. Therefore, the composition containing the strain, or a culture or extract thereof, as an active ingredient for preventing plant diseases has excellent antifungal activity and can thus be used as an environmentally friendly and pollution-free pesticide.
    Type: Grant
    Filed: May 13, 2011
    Date of Patent: November 26, 2013
    Assignee: The Director of Chungcheongbuk-Do Agricultutal Research and Extension Services
    Inventors: Hyo Jung Kang, Ki Su Ahn, Chong Woo Han, Kyung Heon Jeong, See Jung Park, In Gyu Song, Tae Yun, Kyeong Beom Min
  • Patent number: 8580546
    Abstract: A method for fabricating a micro-organ device comprises providing a microscale support having one or more microfluidic channels and one or more micro-chambers for housing a micro-organ and printing a micro-organ on the microscale support using a cell suspension in a syringe controlled by a computer-aided tissue engineering system, wherein the cell suspension comprises cells suspended in a solution containing a material that functions as a three-dimensional scaffold. The printing is performed with the computer-aided tissue engineering system according to a particular pattern. The micro-organ device comprises at least one micro-chamber each housing a micro-organ; and at least one microfluidic channel connected to the micro-chamber, wherein the micro-organ comprises cells arranged in a configuration that includes microscale spacing between portions of the cells to facilitate diffusion exchange between the cells and a medium supplied from the at least one microfluidic channel.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: November 12, 2013
    Assignee: The United States of America as represented by the Administrator of the National Aeronautics and Space Administration
    Inventors: Steve R. Gonda, Robert C. Chang, Binil Starly, Christopher Culbertson, Heidi L. Holtorf, Wei Sun, Julia Leslie
  • Patent number: 8557583
    Abstract: An object of the present invention is to provide a cell culture support making the detachment of a cell sheet easy as well as enabling the formation of a uniform cell sheet.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: October 15, 2013
    Assignees: Dai Nippon Printing Co., Ltd., Tokyo Woman's Medical University, Cellseed Inc.
    Inventors: Masanao Watanabe, Kenichi Hagiwara, Teruo Okano, Masayuki Yamato, Tatsuya Shimizu, Yoshikatsu Akiyama, Hiroya Watanabe, Keisuke Ashiba
  • Patent number: 8530211
    Abstract: Provided herein are methods of using yeast cells to produce ethanol by contacting a mixture comprising xylose with a Spathaspora yeast cell under conditions suitable to allow the yeast to ferment at least a portion of the xylose to ethanol. The methods allow for efficient ethanol production from hydrolysates derived from lignocellulosic material and sugar mixtures including at least xylose and glucose or xylose, glucose and cellobiose.
    Type: Grant
    Filed: April 19, 2012
    Date of Patent: September 10, 2013
    Assignees: Wisconsin Alumni Research Foundation, U.S. Department of Agriculture
    Inventors: Thomas W. Jeffries, Laura B. Willis, Tanya M. Long, Yi-Kai Su